LifeMD Inc (LFMD) PT Lowered to $8 at Freedom Capital Markets

Freedom Capital Markets analyst Ilya Zubkov lowered the price target on LifeMD Inc (NASDAQ: LFMD) to $8.00 (from $11.00) while maintaining a Buy rating.

The analyst comments "We lower our LFMD target price from $11 to $8, reflecting reduced guidance, the WorkSimpli sale, and a weaker near- term outlook for adjusted EBITDA margin. We maintain our Buy rating given the strength of the product pipeline and the potential for accelerated active users growth. ● Telehealth revenue has not yet re-accelerated, but 2026 could be a turning point on product development. ● The WorkSimpli divestiture frees capital to fund Telehealth growth. ● Margins will be pressured by growth investments in the near term. We expect adjusted EBITDA margin to expand in 2H26 on operating leverage."

You May Also Be Interested In

• Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating
• Software M&A heats up: Which SaaS stocks could be next for private equity?
• Datavault AI (DVLT) Will Acquire CyberCatch in an All-Cash Transaction